Product References
Direct Thrombin Inhibitor Dabigatran Compromises Pulmonary Endothelial Integrity in a Murine Model of Breast Cancer Metastasis to the Lungs; the Role of Platelets and Inflammation-Associated Haemostasis.
Frontiers in pharmacology
Smeda M,Stojak M,Przyborowski K,Sternak M,Suraj-Prazmowska J,Kus K,Derszniak K,Jasztal A,Kij A,Kurpinska A,Kieronska-Rudek A,Wojnar-Lason K,Buczek E,Mohaissen T,Chlopicki S
Published figure using Angiopoietin 2 polyclonal antibody (Product # PA5-27297) in Western Blot
Sat Mar 19 00:00:00 EDT 2022
Endothelial-mesenchymal transition induced by metastatic 4T1 breast cancer cells in pulmonary endothelium in aged mice.
Frontiers in molecular biosciences
Smeda M,Jasztal A,Maleki EH,Bar A,Sternak M,Kwiatkowski G,Suraj-Prażmowska J,Proniewski B,Kieronska-Rudek A,Wojnar-Lason K,Skrzypek K,Majka M,Chrabaszcz K,Malek K,Chlopicki S
PA5-27297 was used in Western Blotting to indicate that age-dependent pre-existing endothelial dysfunction in the pulmonary endothelium of 40-week-old mice predisposed them to rapid EndMT progression in the presence of circulating 4T1 breast cancer cells what might contribute to a more severe metastatic breast cancer phenotype in these ageing mice compared to younger mice.
Fri Mar 03 00:00:00 EST 2023
Tumor Angiogenesis Is Differentially Regulated by Phosphorylation of Endothelial Cell Focal Adhesion Kinase Tyrosines-397 and -861.
Cancer research
Pedrosa AR,Bodrug N,Gomez-Escudero J,Carter EP,Reynolds LE,Georgiou PN,Fernandez I,Lees DM,Kostourou V,Alexopoulou AN,Batista S,Tavora B,Serrels B,Parsons M,Iskratsch T,Hodivala-Dilke KM
PA5-27297 was used in Western Blotting to establish the differential requirements of EC-FAK-Y397 and EC-FAK-Y861-phosphorylation in the regulation of EC-signalling and tumor angiogenesis in vivo.
Sun Sep 01 00:00:00 EDT 2019
Dual antiplatelet therapy with clopidogrel and aspirin increases mortality in 4T1 metastatic breast cancer-bearing mice by inducing vascular mimicry in primary tumour.
Oncotarget
Smeda M,Kieronska A,Proniewski B,Jasztal A,Selmi A,Wandzel K,Zakrzewska A,Wojcik T,Przyborowski K,Derszniak K,Stojak M,Kaczor D,Buczek E,Watala C,Wietrzyk J,Chlopicki S
PA5-27297 was used in Western Blotting to establish that distinct platelet-dependent mechanisms inhibited by ASA+Cl treatment promoted cancer malignancy and VM in the presence of primary tumour.
Tue Apr 03 00:00:00 EDT 2018
Nitric oxide deficiency and endothelial-mesenchymal transition of pulmonary endothelium in the progression of 4T1 metastatic breast cancer in mice.
Breast cancer research : BCR
Smeda M,Kieronska A,Adamski MG,Proniewski B,Sternak M,Mohaissen T,Przyborowski K,Derszniak K,Kaczor D,Stojak M,Buczek E,Jasztal A,Wietrzyk J,Chlopicki S
PA5-27297 was used in Western Blotting to suggest that early endothelial dysfunction featured by NO deficiency rather than EndMT, might represent a primary regulatory target to prevent early pulmonary metastasis.
Fri Aug 03 00:00:00 EDT 2018
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.
EMBO molecular medicine
Scholz A,Harter PN,Cremer S,Yalcin BH,Gurnik S,Yamaji M,Di Tacchio M,Sommer K,Baumgarten P,Bähr O,Steinbach JP,Trojan J,Glas M,Herrlinger U,Krex D,Meinhardt M,Weyerbrock A,Timmer M,Goldbrunner R,Deckert M,Braun C,Schittenhelm J,Frueh JT,Ullrich E,Mittelbronn M,Plate KH,Reiss Y
PA5-27297 was used in immunohistochemistry to report angiopoietin-2 as a target in both naive and bevacizumab-treated glioblastoma
Fri Jan 01 00:00:00 EST 2016
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.
EMBO molecular medicine
Scholz A,Harter PN,Cremer S,Yalcin BH,Gurnik S,Yamaji M,Di Tacchio M,Sommer K,Baumgarten P,Bähr O,Steinbach JP,Trojan J,Glas M,Herrlinger U,Krex D,Meinhardt M,Weyerbrock A,Timmer M,Goldbrunner R,Deckert M,Braun C,Schittenhelm J,Frueh JT,Ullrich E,Mittelbronn M,Plate KH,Reiss Y
PA5-27297 was used in immunohistochemistry to report angiopoietin-2 as a target in both naive and bevacizumab-treated glioblastoma
Fri Jan 01 00:00:00 EST 2016